生物
CD44细胞
CD24型
基因敲除
癌症研究
转录组
癌症干细胞
细胞
干细胞
单细胞测序
肝癌
肝细胞癌
细胞培养
细胞生物学
基因
基因表达
遗传学
表型
外显子组测序
作者
Daniel Wai‐Hung Ho,Yu-Man Tsui,Karen Man-Fong Sze,Lo‐Kong Chan,Tan To Cheung,Eva Lee,Pak C. Sham,Stephen Kwok‐Wing Tsui,Terence K. Lee,Irene Oi‐Lin Ng
出处
期刊:Cancer Letters
[Elsevier]
日期:2019-06-10
卷期号:459: 176-185
被引量:127
标识
DOI:10.1016/j.canlet.2019.06.002
摘要
Hepatocellular carcinoma (HCC) is heterogeneous, rendering its current curative treatments ineffective. The emergence of single-cell genomics represents a powerful strategy in delineating the complex molecular landscapes of cancers. In this study, we demonstrated the feasibility and merit of using single-cell RNA sequencing to dissect the intra-tumoral heterogeneity and analyze the single-cell transcriptomic landscape to detect rare cell subpopulations of significance. Exploration of the inter-relationship among liver cancer stem cell markers showed two distinct major cell populations according to EPCAM expression, and the EPCAM+ cells had upregulated expression of multiple oncogenes. We also identified a CD24+/CD44+-enriched cell subpopulation within the EPCAM+ cells which had specific signature genes and might indicate a novel stemness-related cell subclone in HCC. Notably, knockdown of signature gene CTSE for CD24+/CD44+ cells significantly reduced self-renewal ability on HCC cells in vitro and the stemness-related role of CTSE was further confirmed by in vivo tumorigenicity assays in nude mice. In summary, single-cell genomics is a useful tool to delineate HCC intratumoral heterogeneity at better resolution. It can identify rare but important cell subpopulations, and may guide better precision medicine in the long run.
科研通智能强力驱动
Strongly Powered by AbleSci AI